4.6 Review

Gut microbiota, inflammatory bowel disease and colorectal cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer

Kaixi Liu et al.

Summary: The study found that levels of F. nucleatum and pks(+) E. coli in the intestines of colorectal cancer patients were significantly higher, and the combination of multiple biomarkers can effectively distinguish colorectal cancer from colorectal adenomatous polyposis. However, combining bacterial markers with conventional tumor markers can improve the efficiency of noninvasive diagnosis of colorectal cancer.

DISEASE MARKERS (2021)

Review Biochemistry & Molecular Biology

Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies

Jelena Popov et al.

Summary: Ulcerative colitis (UC) is a chronic autoimmune disorder that affects the colonic mucosa. Its etiology remains unclear, but a combination of genetic and environmental factors is suspected. Research has focused on the role of intestinal dysbiosis in UC pathogenesis, and the potential for modulating intestinal inflammation through microbial-targeted therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cell Biology

Faecal microbial biomarkers in early diagnosis of colorectal cancer

Chinasa Valerie Olovo et al.

Summary: Colorectal cancer is a significant global health issue, with early detection playing a crucial role in effective treatment. The gut microbiota has emerged as a potential biomarker for early non-invasive diagnosis of CRC, offering promising sensitivity, specificity, and cost-effectiveness.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Microbiology

Tumor-Associated Microbiota in Proximal and Distal Colorectal Cancer and Their Relationships With Clinical Outcomes

Min Jin et al.

Summary: The study found significant differences in tumor microbiota characteristics between the proximal and distal subsites of colorectal cancer. The differences may indicate distinct risk factors across anatomical subsites, providing a new strategy for precise prevention and treatment of CRC in the future.

FRONTIERS IN MICROBIOLOGY (2021)

Review Pharmacology & Pharmacy

Microbiota and Colorectal Cancer: From Gut to Bedside

Miguel Silva et al.

Summary: Colorectal cancer is a complex condition caused by a combination of environmental, genetic, and epigenetic factors, with disruptions in gut microbiota structure associated with various intestinal diseases, including cancer. Bacteria can induce cellular transformation and promote tumor progression through mechanisms such as biofilm formation and genotoxin secretion. The gut microbiota is also involved in drug metabolism, radiotherapy responses, and targeted immunotherapy, with therapy efficacy varying based on the composition of the host's gut microbiota.

FRONTIERS IN PHARMACOLOGY (2021)

Review Pharmacology & Pharmacy

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention

Marianna Lucafo et al.

Summary: This passage discusses the increased risk of colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients, highlighting the potential different tumorigenesis pathway of IBD-associated CRC (IBD-CRC) compared to sporadic CRC. It also emphasizes the important role of immunomodulators and biologics in interfering with the inflammatory process involved in carcinogenesis for treating IBD patients.

FRONTIERS IN PHARMACOLOGY (2021)

Review Oncology

Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges

Wanru Zhang et al.

Summary: This article summarizes the intimate relationship between detrimental gut microbiota-derived metabolites and CRC, updates the current knowledge about detrimental metabolites in CRC pathogenesis, and critically reviews multiple interventions targeting these metabolites for CRC management.

FRONTIERS IN ONCOLOGY (2021)

Review Nutrition & Dietetics

Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer

Sandeep Appunni et al.

Summary: Dietary factors play a crucial role in modulating gut microbiota and restoring colonic epithelium. A healthy plant-based diet and related supplements are essential in preventing CRC by improving the gut microbiome. Dietary and lifestyle modifications can restrict the growth of harmful organisms.

FRONTIERS IN NUTRITION (2021)

Article Gastroenterology & Hepatology

Age-specific Trends in Colorectal Cancer Incidence for Women and Men, 1935-2017

Rebecca D. Kehm et al.

GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs)

Ryma Toumi et al.

Summary: Inflammatory Bowel Disease (IBD) encompasses Crohn's Disease and Ulcerative Colitis, with undetermined etiology. Common treatments involve medication and surgery. Probiotics, as live microorganisms, play a significant role in regulating the immune system, gut microbiota, and active metabolites.

GASTROENTEROLOGY INSIGHTS (2021)

Letter Medicine, General & Internal

Gut microbiota and health

K. C. Dilip et al.

POSTGRADUATE MEDICINE (2020)

Article Food Science & Technology

Prebiotic, antioxidant and anti-inflammatory properties of edible Amazon fruits

T. F. S. Curimbaba et al.

FOOD BIOSCIENCE (2020)

Review Cell Biology

The Gut Microbiota at the Service of Immunometabolism

Chloe Michaudel et al.

CELL METABOLISM (2020)

Review Gastroenterology & Hepatology

Secondary causes of inflammatory bowel diseases

Yezaz A. Ghouri et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Review Microbiology

Human gut microbiota/microbiome in health and diseases: a review

Eman Zakaria Gomaa

ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2020)

Review Immunology

Gut microbiota in neurodegenerative disorders

Suparna Roy Sarkar et al.

JOURNAL OF NEUROIMMUNOLOGY (2019)

Review Gastroenterology & Hepatology

Colorectal cancer in inflammatory bowel disease: review of the evidence

D. S. Keller et al.

TECHNIQUES IN COLOPROCTOLOGY (2019)

Review Nutrition & Dietetics

Precision Nutrition and the Microbiome, Part I: Current State of the Science

Susan Mills et al.

NUTRIENTS (2019)

Article Multidisciplinary Sciences

Increased abundance of proteobacteria in aggressive Crohn's disease seven years after diagnosis

M. K. Vester-Andersen et al.

SCIENTIFIC REPORTS (2019)

Review Microbiology

Fusobacterium nucleatum - symbiont, opportunist and oncobacterium

Caitlin A. Brennan et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Article Gastroenterology & Hepatology

Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease

Kyohei Nishino et al.

JOURNAL OF GASTROENTEROLOGY (2018)

Review Gastroenterology & Hepatology

Gut microbiota in the pathogenesis of inflammatory bowel disease

Atsushi Nishida et al.

CLINICAL JOURNAL OF GASTROENTEROLOGY (2018)

Review Biochemistry & Molecular Biology

Oxygen as a driver of gut dysbiosis

Fabian Rivera-Chavez et al.

FREE RADICAL BIOLOGY AND MEDICINE (2017)

Review Biotechnology & Applied Microbiology

Proteobacteria: A Common Factor in Human Diseases

G. Rizzatti et al.

BIOMED RESEARCH INTERNATIONAL (2017)

Review Immunology

The gut microbiota and inflammatory bowel disease

Katsuyoshi Matsuoka et al.

SEMINARS IN IMMUNOPATHOLOGY (2015)

Article Gastroenterology & Hepatology

Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis

E. Varela et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)

Article Multidisciplinary Sciences

Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut

Sebastian E. Winter et al.

SCIENCE (2013)

Review Physiology

Gut Microbiota in Health and Disease

Inna Sekirov et al.

PHYSIOLOGICAL REVIEWS (2010)

Article Multidisciplinary Sciences

Diversity of the human intestinal microbial flora

PB Eckburg et al.

SCIENCE (2005)

Review Medicine, General & Internal

Colorectal cancer

J Weitz et al.

LANCET (2005)